Biocellvia is a digital pathology company, offering dedicated histological image analysis solutions for preclinical and clinical research. Their patented technology, MorphoQuant™ based on artificial intelligence, is a decision-making tool that provides quantitative data on pathological characteristics, thus improving the accuracy, objectivity and reproducibility of the data.
For more than ten years, Biocellvia have been working closely with the public and private scientific community (researchers, pathologists, etc.) to develop specific tools for each pathology.
As part of the European scientific program GriponMash, they are putting their expertise in digital pathology at the service of the analysis of liver biopsies, thus contributing to a better understanding of the disease and the optimization of therapeutic strategies.
